Biotage ABShs Aktie
8,97EUR | -0,40EUR | -4,27% |
WKN DE: A0MNB5 / ISIN: SE0000454746
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 463 | 497 | 517 | 674 | 673 |
Umsatz pro Mitarbeiter in Mio. EUR | 2,36 | 2,48 | 3,03 | 2,76 | 3,05 |
Bilanz (in Mio. SEK) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 752 | 774 | 1 031 | 1 447 | 1 323 |
Summe Anlagevermögen | 683 | 1 218 | 1 308 | 3 484 | 3 781 |
Summe Aktiva | 1 434 | 1 992 | 2 339 | 4 931 | 5 104 |
Bilanz (in Mio. SEK) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 444 | 621 | 702 | 1 274 | 991 |
Summe Eigenkapital | 990 | 1 371 | 1 637 | 3 657 | 4 113 |
Summe Passiva | 1 434 | 1 992 | 2 339 | 4 931 | 5 104 |
Adresse
Vimpelgatan 5, 753 18 Uppsala | |
Telefon | +46 (18) 56-59-00 |
Fax | +46 (18) 59-19-22 |
Internet | http://www.biotage.com |
Management
Anders Wikström
Executive Vice President-Operations |
Andrew F. Kellett
Chief Financial Officer |
Daniel Menasco
Director |
Frederic Vanderhaegen
President & Chief Executive Officer |
Karen Lykke Sörensen
Director |
Karen Sørensen
Director |
Kieran P. Murphy
Chairman |
Kugan Sathiyanandarajah
Director |
Lamberstam Philip
Director |
Lisa Egelrud
Executive VP-Quality Assurance Regulatory Affairs |
Magnus Nordstedt
Executive Vice President-IT & Digitalization |
Marc Hummersone
Chief Scientific Officer |
Mark Bradley
Director |
Maryam Poorafshar
Executive Vice President-Research & Development |
Olof Nord
Executive Vice President-Business Development |
Peter von Ehrenheim
Director |
Petra Duprez
Chief Human Resources & Sustainability Officer |
Pär Lundgren
Director |
Raffaella Bombarda
Executive Vice President-Global Marketing |
Scott Carr
President-Americas |
Torben Vedel Stahl Jörgensen
Director |
Åsa Hedin
Director |